Kidney-sparing management for high-risk upper tract urothelial carcinoma: Where do we stand?
作者信息
Shrivastava Nikita
机构信息
Department of Urology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
出版信息
Indian J Urol. 2024 Oct-Dec;40(4):285-286. doi: 10.4103/iju.iju_263_24. Epub 2024 Oct 1.
Abstract
摘要
相似文献
1
Kidney-sparing management for high-risk upper tract urothelial carcinoma: Where do we stand?高危上尿路尿路上皮癌的保留肾单位治疗：我们目前的状况如何？
Indian J Urol. 2024 Oct-Dec;40(4):285-286. doi: 10.4103/iju.iju_263_24. Epub 2024 Oct 1.
2
Nephron-sparing management of upper tract urothelial carcinoma.保留肾单位手术治疗上尿路尿路上皮癌。
Investig Clin Urol. 2021 Jul;62(4):389-398. doi: 10.4111/icu.20210113.
3
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.保留肾单位的输尿管切除术与根治性肾输尿管切除术治疗上尿路上皮癌的肾功能和肿瘤学结局。
J Urol. 2012 Feb;187(2):429-34. doi: 10.1016/j.juro.2011.09.150. Epub 2011 Dec 15.
4
Overcoming Understaging and Undergrading in Upper Tract Urothelial Carcinoma. Comment on Ghoreifi et al. Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma. 2023, , 4495.克服上尿路尿路上皮癌分期和分级不足。对戈雷菲等人的评论。上尿路尿路上皮癌的现代保留肾单位治疗。2023年，，4495。
Cancers (Basel). 2024 Feb 29;16(5):1002. doi: 10.3390/cancers16051002.
5
Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan.上尿路尿路上皮癌的临床实践模式：日本全国性调查
Jpn J Clin Oncol. 2016 Aug;46(8):768-74. doi: 10.1093/jjco/hyw072. Epub 2016 Jun 6.
6
Kidney-sparing Management Versus Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Systematic Review and Meta-analysis.保留肾单位治疗与根治性肾输尿管切除术治疗上尿路尿路上皮癌的系统评价和Meta分析
Asian Pac J Cancer Prev. 2015;16(14):5907-12. doi: 10.7314/apjcp.2015.16.14.5907.
7
Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.GU 癌症中的保器官手术：第 3 部分——上尿路、膀胱和尿道尿路上皮癌的保器官手术。
Int Urol Nephrol. 2019 Nov;51(11):1903-1911. doi: 10.1007/s11255-019-02232-z. Epub 2019 Jul 27.
8
Open surgical partial nephrectomy for upper tract urothelial carcinoma.开放性手术部分肾切除术治疗上尿路尿路上皮癌。
Int J Urol. 2014 Apr;21(4):409-12. doi: 10.1111/iju.12301. Epub 2013 Oct 17.
9
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.保留肾单位手术与根治性肾输尿管切除术治疗上尿路上皮癌的肿瘤学结局：EAU 非肌肉浸润性膀胱癌指南小组的系统评价。
Eur Urol. 2016 Dec;70(6):1052-1068. doi: 10.1016/j.eururo.2016.07.014. Epub 2016 Jul 28.
10
Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.上尿路尿路上皮癌：向保留肾单位治疗模式的转变。
World J Nephrol. 2016 Mar 6;5(2):158-65. doi: 10.5527/wjn.v5.i2.158.
本文引用的文献
1
Endoscopic Cryoablation Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的内镜冷冻消融术与根治性肾输尿管切除术对比研究
Eur Urol Oncol. 2024 Dec;7(6):1453-1461. doi: 10.1016/j.euo.2024.04.012. Epub 2024 May 1.
2
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南：2023 年更新版。
Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24.
3
Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.影响上尿路尿路上皮癌患者生存的病理因素：系统评价和荟萃分析。
Int Braz J Urol. 2022 May-Jun;48(3):406-455. doi: 10.1590/S1677-5538.IBJU.2020.1032.
4
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.在上尿路尿路上皮癌中的辅助化疗（POUT 试验）：一项 3 期、开放标签、随机对照试验。
Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5.
Zotero 插件